Ovary Cancer Clinical Trials

15 recruiting

Ovary Cancer Trials at a Glance

19 actively recruiting trials for ovary cancer are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Chicago, Philadelphia, and Roma. Lead sponsors running ovary cancer studies include Northwestern University, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, and Institut Paoli-Calmettes.

Browse ovary cancer trials by phase

Treatments under study

About Ovary Cancer Clinical Trials

Looking for clinical trials for Ovary Cancer? There are currently 15 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ovary Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ovary Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 119 of 19 trials

Recruiting
Phase 1

DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer

Ovarian CancerOvarian CarcinomaRecurrent Platinum-Resistant Ovarian Carcinoma+1 more
Elizabeth Stover, MD, PhD30 enrolled3 locationsNCT06964009
Recruiting
Phase 2

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

Fallopian Tube CancerOvary CancerPeritoneal Cancer
University of Colorado, Denver53 enrolled5 locationsNCT05887609
Recruiting
Not Applicable

Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy

Endometrial CancerUterine CancerOvary Cancer
Northwestern University30 enrolled1 locationNCT05990426
Recruiting
Phase 1

A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors

Metastatic Breast CancerEndometrial CancerAdvanced Solid Tumor+6 more
Institut Paoli-Calmettes27 enrolled1 locationNCT05143970
Recruiting
Phase 2

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

Breast CancerBreast CarcinomaBreast Neoplasm+34 more
University of California, Davis86 enrolled1 locationNCT06268665
Recruiting
Not Applicable

Multimedia Aid for Genetic Testing in Gynecologic Oncology

Endometrial CancerOvary Cancer
UNC Lineberger Comprehensive Cancer Center30 enrolled1 locationNCT07084168
Recruiting
Phase 2

Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer

Fallopian Tube CancerOvary CancerPrimary Peritoneal Cavity Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins18 enrolled2 locationsNCT06617923
Recruiting
Not Applicable

No-Stoma Policy in Advanced Ovarian Cancer Surgery

Ovary Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS395 enrolled1 locationNCT07213193
Recruiting
Phase 2

RC48 in Combination With AK104 and Bevacizumab in OCCC

Ovary Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University39 enrolled1 locationNCT06540729
Recruiting
Phase 3

Measuring Oncological Value of Exercise and Statin

Breast CancerMetastatic Breast CancerOvarian Cancer+9 more
Tampere University Hospital240 enrolled1 locationNCT05796973
Recruiting
Not Applicable

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

Ovarian CancerOvarian CarcinomaPrimary Peritoneal Carcinoma+11 more
Memorial Sloan Kettering Cancer Center35 enrolled7 locationsNCT05429970
Recruiting
Not Applicable

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

Cervical CancerEndometrial CancerUterine Cancer+4 more
Northwestern University192 enrolled1 locationNCT05743517
Recruiting

Mesenteric Infiltration in Ovarian Cancer

Ovary Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS510 enrolled1 locationNCT06331130
Recruiting
Not Applicable

GYNecologic Cancer-Related COGnitive Impairment

Ovarian CancerEndometrial CancerUterine Cancer+4 more
Northwestern University60 enrolled1 locationNCT06662435
Recruiting

Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study

Ovary Cancer
University of Tennessee Graduate School of Medicine10 enrolled1 locationNCT06800105
Recruiting
Not Applicable

The Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in Women

Ovary Cancer
Tongji Hospital198 enrolled1 locationNCT06556342
Recruiting
Phase 1

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

Breast Cancer FemaleColorectal, CancerPancreatic Cancer+4 more
UTC Therapeutics Inc.24 enrolled1 locationNCT06256055
Recruiting

Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker

Ovarian NeoplasmsOvary CancerOvarian Cysts
University of Aarhus300 enrolled1 locationNCT05763511
Recruiting
Phase 2

Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer

Ovarian CancerFallopian Tube CancerOvary Cancer+4 more
University College, London80 enrolled1 locationNCT05080556